Stockpolly
Search
BCTX · NASDAQ · Biotechnology

BriaCell Therapeutics (BCTX)

Develops HLA-matched cell immunotherapies for metastatic breast cancer and other solid tumors.

$3.57
Pre-market−0.01 (−0.28%)
At close$3.58(−1.38%)
Watchlist

In millions of USD, except per-share figures

In millionsQ4 FY23Jul 2023Q1 FY24Oct 2023Q2 FY24Jan 2024Q3 FY24Apr 2024Q4 FY24Jul 2024Q1 FY25Oct 2024Q2 FY25Jan 2025Q3 FY25Apr 2025Q4 FY25Jul 2025Q1 FY26Oct 2025Q2 FY26Jan 2026Q3 FY26Apr 2026
Cost of revenue000000000000
Gross profit000000000000
1012131387119121288
Research & development791110658710986
322222222222
General & administrative322222220222
Other expenses0000000000−30
Operating income−10−12−13−13—−7−11−9−12−12−8−8
720−2155−1101000
Interest income000000000000
Interest expense000000000000
Other non-operating income−700−1500000000
Income before tax−38−152—−8−9−9−11−12−7−7
Net income from continuing operations−38−152—−8−9−9−11−12−7−7
Net income−38−152−2———−11−11−7−7
EPS, basic−$22.50$5.70−$10.64$21.68−$1.40−$4.55−$3.43−$1.64−$5.87−$4.35−$2.62−$1.00
EPS, diluted−$22.85−$7.50−$10.64$21.68−$10.02−$4.55−$22.77−$1.64−$5.87−$4.35−$2.62−$1.00
Weighted average shares, basic111112322237
Weighted average shares, diluted111112322237
EBITDA−3−12−132−8—−11−9−12−12−8−7
Depreciation & amortization000000000000
EBIT−3−12−132—−7−11−9−12−12−8−7